295 related articles for article (PubMed ID: 32855526)
1. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
2. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
[TBL] [Abstract][Full Text] [Related]
3. S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis.
Mahmood N; Arakelian A; Cheishvili D; Szyf M; Rabbani SA
J Cell Mol Med; 2020 Sep; 24(18):10322-10337. PubMed ID: 32720467
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
[TBL] [Abstract][Full Text] [Related]
5. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Buocikova V; Longhin EM; Pilalis E; Mastrokalou C; Miklikova S; Cihova M; Poturnayova A; Mackova K; Babelova A; Trnkova L; El Yamani N; Zheng C; Rios-Mondragon I; Labudova M; Csaderova L; Kuracinova KM; Makovicky P; Kucerova L; Matuskova M; Cimpan MR; Dusinska M; Babal P; Chatziioannou A; Gabelova A; Rundén-Pran E; Smolkova B
Biomed Pharmacother; 2022 Mar; 147():112662. PubMed ID: 35091237
[TBL] [Abstract][Full Text] [Related]
6. Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A.
Al-Kharashi LA; Bakheet T; AlHarbi WA; Al-Moghrabi N; Aboussekhra A
Mol Carcinog; 2021 Nov; 60(11):784-795. PubMed ID: 34473867
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
8. Targeting DNA methylation for treating triple-negative breast cancer.
Yu J; Zayas J; Qin B; Wang L
Pharmacogenomics; 2019 Nov; 20(16):1151-1157. PubMed ID: 31755366
[TBL] [Abstract][Full Text] [Related]
9. Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance.
Sharma V; Montano MM
Sci Rep; 2020 Dec; 10(1):21015. PubMed ID: 33273553
[TBL] [Abstract][Full Text] [Related]
10. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
Frazzi R; Cusenza VY; Pistoni M; Canovi L; Cascione L; Bertoni F; Merli F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751409
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.
Ceccarelli V; Ronchetti S; Marchetti MC; Calvitti M; Riccardi C; Grignani F; Vecchini A
Biochim Biophys Acta Gene Regul Mech; 2020 Feb; 1863(2):194481. PubMed ID: 31923609
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer.
Zheng Y; Wang Z; Wei S; Liu Z; Chen G
Cancer Lett; 2021 Feb; 499():148-163. PubMed ID: 33253790
[TBL] [Abstract][Full Text] [Related]
13. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
14. Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development.
Wang P; Chu W; Zhang X; Li B; Wu J; Qi L; Yu Y; Zhang H
Int J Biochem Cell Biol; 2018 Dec; 105():41-51. PubMed ID: 30287284
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells.
Wang HC; Chen CW; Yang CL; Tsai IM; Hou YC; Chen CJ; Shan YS
Cancer Immunol Res; 2017 Oct; 5(10):885-897. PubMed ID: 28835422
[TBL] [Abstract][Full Text] [Related]
16. Comparison of DNMT1 inhibitors by methylome profiling identifies unique signature of 5-aza-2'deoxycytidine.
Mackin SJ; O'Neill KM; Walsh CP
Epigenomics; 2018 Aug; 10(8):1085-1101. PubMed ID: 30070602
[TBL] [Abstract][Full Text] [Related]
17. The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progression.
Al-Salihi M; Yu M; Burnett DM; Alexander A; Samlowski WE; Fitzpatrick FA
Epigenetics; 2011 Aug; 6(8):1021-8. PubMed ID: 21725200
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancer.
Kim DH; Kim HM; Huong PTT; Han HJ; Hwang J; Cha-Molstad H; Lee KH; Ryoo IJ; Kim KE; Huh YH; Ahn JS; Kwon YT; Soung NK; Kim BY
BMB Rep; 2019 May; 52(5):342-347. PubMed ID: 31068247
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
Yu J; Qin B; Moyer AM; Nowsheen S; Liu T; Qin S; Zhuang Y; Liu D; Lu SW; Kalari KR; Visscher DW; Copland JA; McLaughlin SA; Moreno-Aspitia A; Northfelt DW; Gray RJ; Lou Z; Suman VJ; Weinshilboum R; Boughey JC; Goetz MP; Wang L
J Clin Invest; 2018 Jun; 128(6):2376-2388. PubMed ID: 29708513
[TBL] [Abstract][Full Text] [Related]
20. DNMT1: A key drug target in triple-negative breast cancer.
Wong KK
Semin Cancer Biol; 2021 Jul; 72():198-213. PubMed ID: 32461152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
